Schering And MediGene Collaborate On Human Papilloma Virus Treatment

medigeneSchering AG and has announced the formation of a world-wide strategic alliance to develop and commercialise MediGene’s Viral Vaccine for the treatment of precancerous lesions of the cervix caused by human papilloma viruses (HPV). Schering has been granted a world-wide exclusive license with the right to grant sublicenses.

MediGene has an option for distribution of the vaccine in countries in which Schering decides not to commercialise.

The total deal value excluding undisclosed royalties on sales could amount to euro 55 million.

This amount includes the jointly agreed R&D budget to which MediGene will partially contribute up to proof of concept as well as up-front and milestone payments.

Under the terms of the agreement MediGene will be responsible for all research and pre-clinical studies.

The phase I/II study for proof of concept will be jointly conducted by MediGene and Schering.

Further clinical studies as well as registration and promotion will be undertaken by Schering.

MediGene will participate in Strategic Marketing meetings and develop a concept for medical education and vaccination in Asia and Latin America.

Prof. Dr. h.c. Guenter Stock, member of the Board of Executive Directors of Schering AG. commented, “The present treatments available for precancerous lesions very often become invasive and may cause infertility or heavy disorders in following pregnancies. For cervical cancer there is solely radical surgical treatment with serious side effects. MediGene’s therapeutic vaccine could offer a thorough treatment without any side effects to women with pre-cancerous lesions who are at risk for progression to cervical cancer. There is a need for this treatment and we believe in MediGene’s promising chimeric virus- like particles (CVLP) technology. Furthermore the unique advantage of the CVLPs is the combination of treatment and prophylaxis in one product which prevents re-infection of treated patients. Schering is the optimal partner for MediGene’s vaccine due to the company’s expertise in both gynecology and oncology”, commented Dr. Peter Heinrich, MediGene’s CEO. “This cooperation is a major step for MediGene as it underlines the potential of MediGene’s CVLP- technology. We will now be able to pursue the clinical development of the vaccine together with a strong, experienced partner, with great promotional strength in women’s health.” MediGene’s CVLP-technology is based on chimeric virus-like particles (CVLPs) built up by a HPV-L1E7 fusion-protein, which self-assembles into virus-like particles able to cause a pseudo-infection.

The CVLPs stimulate the immune system both to prevent infections (prophylactic immunization) and to destroy HPV infected cells (therapeutic immunization). The particles consist of a HPV 16 – L1E7 fusion-protein with the double function: L1 structural protein induces neutralizing antibodies whereas the shortened E7 regulatory protein induces a cytotoxic T cell response.

Legal Steroids

Dragon Pharma is producing a large range of steroids Femara on Sale.

Shopping Dragon Pharma LLC of Top Quality

Trenbolone 50

Injectable Anabolic Steroid
Basal Ingredient: Trenbolone Suspension
Branded by: Dragon Pharma
Amount: 1 X 10 mL vial (50 mg/mL)

Deca 500

Injectable Anabolic Steroid
Primary Substance: Nandrolone Decanoate
Produced by: Dragon Pharmaceutical
Pack: 1 X 10 ml (500 mg/ml)

Clomid - Cheap Price

Administration: Oral
Active Chemical Name: Clomiphene Citrate
Producer: Dragon Pharmaceutical
Pack: 20 x 100 tabs (50 mg/pill)
Price: 20 x $58.00

Trenbolone 100 - Bulk Price

Administration: Injection
Basic Substance: Trenbolone Acetate
Produced by: Dragon Pharmaceutical
Package: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $60.00

Dianabol 20 - Cheap Price

Administration: Oral
Basic Component: Methandrostenolone
Produced by: Dragon Pharma Labs
Package: 20 x 100 pastilles (20 mg/tablet)
Price: 20 x $32.00

Trenbolone 200 [10 Vials]

Injectable Steroid for Muscle Growth
Main Ingredient: Trenbolone Enanthate
Produced by: Dragon Pharmaceutical
10 Vials [10 mL per Vial (200 mg/ml)]
Price: 10 x $77.00 = $770.00 in Total

Cut Mix 150 [10 Vials]

Injectable Steroid for Muscle Growth
Mix of:
- 50mg Testosterone Propionate
- 50mg Drostanolone Propionate
- 50mg Trenbolone Acetate
Produced by: Dragon Pharma LLC
10 Vials [10 mL per Vial (150 mg/ml)]
Price: 10 x $52.00 = $520.00 in Total

Propionat 100

Injectable Steroid for Muscle Growth
Primary Constituent: Testosterone Propionate
Produced by: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (100 mg/mL)

Cypionat 250

Injectable Steroid for Muscle Growth
Base Substance: Testosterone Cypionate
Made by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (250 mg/mL)

Suspension 100

Injectable Steroid for Muscle Growth
Prime Component: Testosterone Suspension
Branded by: Dragon Pharma
10 mL Sterile Multi-dose Vial (100 mg/mL)


Prime Ingredient: Tamoxifen Citrate
Producer: Dragon Pharmaceuticals
Package: 100 pills (50 mg/tab)


Active Component: Oxymetholone
Made by: Dragon Pharma Labs
Pack: 100 pills (50 mg/pastille)